| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA990004587980403321 |
|
|
Autore |
Descartes, René <1596-1650> |
|
|
Titolo |
Oeuvres / de Descartes ; precedee d'une introduction oar M. Jules Simon |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Paris : Charpentier Lib.-Ed., 1857 |
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Locazione |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Discours sur la Methode; Meditations; Traite' des passions. |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910781556703321 |
|
|
Autore |
Healy David, MRC Psych |
|
|
Titolo |
Pharmageddon [[electronic resource] /] / David Healy |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Berkeley, : University of California Press, c2012 |
|
|
|
|
|
|
|
ISBN |
|
1-283-36974-5 |
9786613369741 |
0-520-95181-6 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (315 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
They used to call it medicine -- Medicine and the marketeers -- Follow the evidence -- Doctoring the data -- Trussed in guidelines -- The |
|
|
|
|
|
|
|
|
|
|
|
mismeasurement of medicine -- The eclipse of care -- Pharmageddon. |
|
|
|
|
|
|
Sommario/riassunto |
|
This searing indictment, David Healy's most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities. Healy, who was the first to draw attention to the now well-publicized suicide-inducing side effects of many anti-depressants, attributes our current state of affairs to three key factors: product rather than process patents on drugs, the classification of certain drugs as prescription-only, and industry-controlled drug trials. These developments have tied the survival of pharmaceutical companies to the development of blockbuster drugs, so that they must overhype benefits and deny real hazards. Healy further explains why these trends have basically ended the possibility of universal health care in the United States and elsewhere around the world. He concludes with suggestions for reform of our currently corrupted evidence-based medical system. |
|
|
|
|
|
|
|
| |